Trim33-deficient tumors had a significantly increased number of CD3-positive cells (Supplementary Fig. 7h), suggesting that loss of Trim33 can promote tumor infiltration by T cells, contributing to delayed tumor development. The gene discussed is TRIM33; the disease is neoplasm.